Group items tagged

Scientists in central Germany are working on a method with which they reckon they could diagnose Alzheimer's disease years before any symptoms are noticed - by looking up patients' noses.

The device could diagnose disease in the developing world and enable rapid drug screening.

Harvard's new "open collection" contributes to the understanding of the global, social-history, and public-policy implications of diseases and offers important historical perspectives on the science and the public policy of epidemiology today.

Free Download - StanfordUniversity - January 22, 2009 - Karl Deisseroth is pioneering bold new treatments for depression and other psychiatric diseases. By sending pulses of light into the brain, Deisseroth can control neural activity with remarkable precision. In this short talk, Deisseroth gives an thoughtful and awe-inspiring overview of his Stanford University lab's groundbreaking research in "optogenetics".

Harvard researchers have created nanodevices made of DNA that self-assemble and can be programmed to move and change shape on demand. The nanodevice structure is based on the principle of tensegrity: its strength and stability results from the way it distributes and balances the counteracting forces of tension and compression. This new technology could lead to nanoscale medical devices and drug delivery systems, such as virus mimics that introduce drugs directly into diseased cells. Or it could one day be used to reprogram human stem cells to regenerate different kinds of injured organs and tissue.

ScienceDaily (Feb. 18, 2011) - A team of biologists, clinical oncologists, pathologists and information scientists has established a strategy for identifying biomarkers. If a particular pattern of these biomarkers can be detected in the blood, this indicates a cancerous disease. An interdisciplinary research breakthrough that opens many doors.

ScienceDaily (May 13, 2011) - Japanese and U.S. scientists in the young field of epigenetics have reported a rationale as to how specific genes are silenced and others are not. Because this effect can be reversed, it may be possible to devise therapies for cancer and other diseases using this information.

A new new brain imaging system that can identify a subject's simple thoughts may lead to clearer diagnoses for Alzheimer's disease or schizophrenia - as well as possibly paving the way for reading people's minds. Michael Greicius at Stanford University in California and colleagues used functional magnetic resonance imaging (fMRI) to identify patterns of brain activity associated with different mental states. He asked 14 volunteers to do one of four tasks: sing songs silently to themselves; recall the events of the day; count backwards in threes; or simply relax. Participants were given a 10-minute period during which they had to do this. For the rest of that time they were free to think about whatever they liked. The participants' brains were scanned for the entire 10 minutes, and the patterns of connectivity associated with each task were teased out by computer algorithms that compared scans from several volunteers doing the same task. This differs from previous experiments, in which the subjects were required to perform mental activities at specific times and the scans were then compared with brain activity when they were at rest. Greicius reasons his method encourages "natural" brain activity more like that which occurs in normal thought.

Scientists say they have found a way to disarm the AIDS virus in research that could lead to a vaccine.  Researchers have discovered that if they eliminate a cholesterol membrane surrounding the virus, HIV cannot disrupt communication among disease-fighting cells and the immune system returns to normal.